Je was op zoek naar: holter (Engels - Sloveens)

holter substudy
holterska podštudija

ms uta-maria kuder, justizministerin des landes mecklenburg-vorpommern, to replace mr holter;
ga. uta-maria kuder, justizministerin des landes mecklenburg-vorpommern, ki zamenja g. holterja;

two members’ seats on the committee of the regions have become vacant following the resignation of mr sinner and the end of the mandate of mr holter.
zaradi odstopa g. sinnerja in zaradi izteka mandata g. holterja sta se sprostili dve mesti članov odbora regij.

during the holter substudy in plato, more patients had ventricular pauses >3 seconds with ticagrelor than with clopidogrel during the acute phase of their acs.
v holterski podštudiji plato je imelo med akutno fazo acs ventrikularne pavze, ≥3 sekund, več bolnikov, ki so dobivali tikagrelor, kot bolnikov, ki so dobivali klopidogrel.

no proarrhythmic effects were observed in 3,162 patients treated with ranexa based on 7-day holter monitoring in the merlin-timi 36 study.
v študiji merlin-timi 36 niso opazili proaritmičnih učinkov pri 3162 bolnikih, ki so prejemali zdravilo ranexa, na podlagi 7-dnevnega holterjevega spremljanja.

no clinically significant effects of brimica genuair on cardiac rhythm were observed on 24-hour holter monitoring in a subset of 551 patients, of whom 114 received brimica genuair twice daily.
poleg tega niso opazili nobenih klinično pomembnih učinkov zdravila brimica genuair na srčni ritem v 24-urnem spremljanju z napravo holter v podskupini 551 bolnikov, od katerih jih je 114 prejemalo zdravilo brimica genuair dvakrat na dan.

no effect on qt interval was reported in a randomised, double-blind, placebo, and active-controlled study using standard and holter electrocardiography.
v randomizirani, dvojno slepi, s placebom in aktivno kontrolirani študiji, v kateri so uporabljali standardno in holter elektrokardiografijo, niso opažali učinka na qt interval.

cardiac electrophysiology no effect on qt interval was reported in a randomised, double-blind, placebo, and active-controlled study using standard and holter electrocardiography.
elektrofiziologija srca v randomizirani, dvojno slepi, s placebom in aktivno kontrolirani študiji, v kateri so uporabljali standardno in holter elektrokardiografijo, niso opažali učinka na qt interval.

in addition, no clinically significant effects of bretaris genuair on cardiac rhythm were observed on 24-hour holter monitoring after 3 months treatment of 336 patients (of whom 164 received bretaris genuair 322 µg twice daily).
poleg tega niso opazili nobenih klinično pomembnih učinkov zdravila bretaris genuair na srčni ritem v 24-urnem spremljanju s holter napravo po 3 mesecih zdravljenja 336 bolnikov (od katerih jih je 164 prejemalo zdravilo bretaris genuair 322 µg dvakrat na dan).